Abiopharma

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing

uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer

Ocugen To Present at BIO International Convention 2025

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Cybin - Cybin to Participate in the 2025 Psychedelic Science Conference

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Cybin to Participate in the 2025 Psychedelic Science Conference

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

Avanzanite annuncia la partnership paneuropea con Agios per lanciare mitapivat nelle malattie ematologiche rare

Novavaxs COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial